Target Price | €29.78 |
Price | €28.45 |
Potential |
4.69%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target SCHOTT Pharma 2026 .
The average SCHOTT Pharma target price is €29.78.
This is
4.69%
register free of charge
€38.85
36.56%
register free of charge
€20.20
29.00%
register free of charge
|
|
A rating was issued by 19 analysts: 14 Analysts recommend SCHOTT Pharma to buy, 3 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the SCHOTT Pharma stock has an average upside potential 2026 of
4.69%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Revenue Million € | 957.09 | 1,039.00 |
6.51% | 8.56% | |
EBITDA Margin | 26.70% | 25.69% |
10.16% | 3.79% | |
Net Margin | 15.64% | 15.06% |
7.44% | 3.71% |
15 Analysts have issued a sales forecast SCHOTT Pharma 2025 . The average SCHOTT Pharma sales estimate is
This results in the following potential growth metrics:
15 Analysts have issued an SCHOTT Pharma EBITDA forecast 2025. The average SCHOTT Pharma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 SCHOTT Pharma Analysts have issued a net profit forecast 2025. The average SCHOTT Pharma net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Sep '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 0.99 | 1.04 |
1.98% | 5.05% | |
P/E | 27.24 | |
EV/Sales | 4.13 |
15 Analysts have issued a SCHOTT Pharma forecast for earnings per share. The average SCHOTT Pharma EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Mar 09 2025 |
STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
EQUI.TS |
Locked
➜
Locked
|
Locked | Feb 16 2025 |
ODDO BHF |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
EQUI.TS |
Locked
➜
Locked
|
Locked | Dec 19 2024 |
DZ BANK |
Locked
➜
Locked
|
Locked | Dec 18 2024 |
Analyst Rating | Date |
---|---|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 31 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Mar 09 2025 |
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Feb 20 2025 |
Locked
EQUI.TS:
Locked
➜
Locked
|
Feb 16 2025 |
Locked
ODDO BHF:
Locked
➜
Locked
|
Feb 12 2025 |
Locked
EQUI.TS:
Locked
➜
Locked
|
Dec 19 2024 |
Locked
DZ BANK:
Locked
➜
Locked
|
Dec 18 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.